Brian T. Helfand, Ph.D. - Publications

2003 Northwestern University, Evanston, IL 
Cell Biology, Molecular Neuroscience

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Selkirk CG, Helfand BT. To PSA or not to PSA? Still a question for men with a family history of prostate cancer. Bju International. 117: 545. PMID 26969030 DOI: 10.1111/Bju.13372  0.96
2016 Lindquist KJ, Paris PL, Hoffmann TJ, Cardin NJ, Kazma R, Mefford JA, Simko JP, Ngo V, Chen Y, Levin AM, Chitale D, Helfand BT, Catalona WJ, Rybicki BA, Witte JS. Mutational landscape of aggressive prostate tumors in African American men. Cancer Research. PMID 26921337 DOI: 10.1158/0008-5472.Can-15-1787  0.96
2016 Stacey SN, Kehr B, Gudmundsson J, Zink F, Jonasdottir A, Gudjonsson SA, Sigurdsson A, Halldorsson BV, Agnarsson BA, Benediktsdottir KR, Aben KK, Vermeulen SH, Cremers RG, Panadero A, Helfand BT, et al. Insertion of an SVA-E retrotransposon into the CASP8 gene is associated with protection against prostate cancer. Human Molecular Genetics. PMID 26740556 DOI: 10.1093/Hmg/Ddv622  0.96
2016 Na R, Ye D, Qi J, Liu F, Lin X, Helfand B, Brendler C, Conran C, Gong J, Wu Y, Gao X, Chen Y, Zheng S, Mo Z, Ding Q, et al. Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases Asian Journal of Andrology. 18: 525-529. DOI: 10.4103/1008-682X.179857  0.96
2015 Welliver C, Sulaver R, Whittington A, Helfand BT, Çakır ÖO, Griffith JW, McVary KT. Analyzing Why Men Seek Treatment for Lower Urinary Tract Symptoms and Factors Associated With Nonimprovement. Urology. 86: 862-7. PMID 26299465 DOI: 10.1016/J.Urology.2015.08.006  0.96
2015 Helfand BT. Temporary erectile dysfunction after prostate biopsy. Bju International. 116: 164. PMID 26202006 DOI: 10.1111/Bju.13022  0.96
2015 Anderson BB, Pariser JJ, Helfand BT. Comparison of Patients Undergoing PVP Versus TURP for LUTS/BPH. Current Urology Reports. 16: 525. PMID 26077354 DOI: 10.1007/S11934-015-0525-7  0.96
2015 Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, et al. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Human Genetics. 134: 439-50. PMID 25715684 DOI: 10.1007/S00439-015-1534-9  0.96
2015 Roy HK, Brendler CB, Subramanian H, Zhang D, Maneval C, Chandler J, Bowen L, Kaul KL, Helfand BT, Wang CH, Quinn M, Petkewicz J, Paterakos M, Backman V. Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept study. Plos One. 10: e0115999. PMID 25706755 DOI: 10.1371/Journal.Pone.0115999  0.96
2015 Helfand BT, Catalona WJ, Xu J. A genetic-based approach to personalized prostate cancer screening and treatment. Current Opinion in Urology. 25: 53-8. PMID 25405931 DOI: 10.1097/Mou.0000000000000130  0.96
2015 Grin B, Loeb S, Roehl K, Cooper PR, Catalona WJ, Helfand BT. A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease. Bju International. 115: 101-5. PMID 24952954 DOI: 10.1111/Bju.12847  0.96
2014 Swanson DE, Polackwich AS, Helfand BT, Masson P, Hwong J, Dugi DD, Martinez Acevedo AC, Hedges JC, McVary KT. Penile fracture: outcomes of early surgical intervention. Urology. 84: 1117-21. PMID 25443914 DOI: 10.1016/J.Urology.2014.07.034  0.96
2014 Frederick LR, Cakir OO, Arora H, Helfand BT, McVary KT. Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients. The Journal of Sexual Medicine. 11: 2546-53. PMID 25059314 DOI: 10.1111/Jsm.12647  0.96
2014 Helfand BT, Catalona WJ. The epidemiology and clinical implications of genetic variation in prostate cancer. The Urologic Clinics of North America. 41: 277-97. PMID 24725490 DOI: 10.1016/J.Ucl.2014.01.001  0.96
2014 Donin NM, Loeb S, Cooper PR, Roehl KA, Baumann NA, Catalona WJ, Helfand BT. Genetically adjusted prostate-specific antigen values may prevent delayed biopsies in African-American men. Bju International. 114: E50-5. PMID 24712975 DOI: 10.1111/Bju.12647  0.96
2014 Reinhardt D, Helfand BT, Cooper PR, Roehl KA, Catalona WJ, Loeb S. Prostate cancer risk alleles are associated with prostate cancer volume and prostate size. The Journal of Urology. 191: 1733-6. PMID 24345439 DOI: 10.1016/J.Juro.2013.12.030  0.96
2014 Cohn JA, Dangle PP, Wang CE, Brendler CB, Novakovic KR, McGuire MS, Helfand BT. The prognostic significance of perineural invasion and race in men considering active surveillance. Bju International. 114: 75-80. PMID 24106869 DOI: 10.1111/Bju.12463  0.96
2014 Cohn JA, Wang CE, Lakeman JC, Silverstein JC, Brendler CB, Novakovic KR, McGuire MS, Helfand BT. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation. Urologic Oncology. 32: 41.e23-30. PMID 23911680 DOI: 10.1016/J.Urolonc.2013.04.013  0.96
2014 McGuire BB, Anglim B, Loeb S, Helfand BT, Grainger R, Flynn R, McDermott T, Hu Q, Cooper PR, Fennell A, Catalona WJ, Thornhill J. Radical prostatectomy outcomes during prostate-specific antigen era in Ireland compared to a matched American population Journal of Clinical Urology. 7: 170-175. DOI: 10.1177/2051415813496995  0.96
2013 Hartman RJ, Helfand BT, Lin WW. The use of adhesion barrier film as an alternative to omental wrap in open ureterolysis. The Canadian Journal of Urology. 20: 7064-6. PMID 24331350  0.96
2013 Helfand BT, Loeb S, Hu Q, Cooper PR, Roehl KA, McGuire BB, Baumann NA, Catalona WJ. Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies. The Journal of Urology. 189: 1697-701. PMID 23246478 DOI: 10.1016/J.Juro.2012.12.023  0.96
2013 Helfand BT, Hu Q, Loeb S, McVary KT, Catalona WJ. Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility. The Journal of Urology. 189: 845-8. PMID 23159463 DOI: 10.1016/J.Juro.2012.11.044  0.96
2013 Helfand BT, Glaser AP, Rimar K, Zargaroff S, Hedges J, McGuire BB, Catalona WJ, McVary KT. Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy. Bju International. 111: 38-43. PMID 22639942 DOI: 10.1111/J.1464-410X.2012.11268.X  0.96
2013 Banks JA, McGuire BB, Loeb S, Shrestha S, Helfand BT, Catalona WJ. Bacteriuria and antibiotic resistance in catheter urine specimens following radical prostatectomy. Urologic Oncology. 31: 1049-53. PMID 22285005 DOI: 10.1016/J.Urolonc.2011.12.008  0.96
2012 Gudmundsson J, Sulem P, Gudbjartsson DF, Masson G, Agnarsson BA, Benediktsdottir KR, Sigurdsson A, Magnusson OT, Gudjonsson SA, Magnusdottir DN, Johannsdottir H, Helgadottir HT, Stacey SN, Jonasdottir A, Olafsdottir SB, ... ... Helfand BT, et al. A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer. Nature Genetics. 44: 1326-9. PMID 23104005 DOI: 10.1038/Ng.2437  0.96
2012 Helfand BT, Lee JY, Sharp V, Foster H, Naslund M, Williams OD, McVary KT. Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial. The Journal of Urology. 188: 2288-93. PMID 23083656 DOI: 10.1016/J.Juro.2012.07.104  0.96
2012 Glaser AP, Novakovic K, Helfand BT. The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety. Current Urology Reports. 13: 447-54. PMID 22935886 DOI: 10.1007/S11934-012-0277-6  0.96
2012 Sheth KR, Sharma V, Helfand BT, Cashy J, Smith K, Hedges JC, Köhler TS, Woodruff TK, Brannigan RE. Improved fertility preservation care for male patients with cancer after establishment of formalized oncofertility program. The Journal of Urology. 187: 979-86. PMID 22264454 DOI: 10.1016/J.Juro.2011.10.154  0.96
2012 Mazur DJ, Helfand BT, McVary KT. Influences of neuroregulatory factors on the development of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction in aging men. The Urologic Clinics of North America. 39: 77-88. PMID 22118347 DOI: 10.1016/J.Ucl.2011.09.005  0.96
2012 McGuire BB, Helfand BT, Kundu S, Hu Q, Banks JA, Cooper P, Catalona WJ. Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance. Bju International. 110: 338-43. PMID 22077888 DOI: 10.1111/J.1464-410X.2011.10750.X  0.96
2012 Zhao LC, Meeks JJ, Helfand BT, Ross FR, Herr HW, Kundu SD. Screening urine analysis before bacille Calmette-Guérin instillation does not reduce the rate of infectious complications. Bju International. 109: 1819-21. PMID 22077819 DOI: 10.1111/J.1464-410X.2011.10735.X  0.96
2012 Helfand BT, Wang Y, Pfleghaar K, Shimi T, Taimen P, Shumaker DK. Chromosomal regions associated with prostate cancer risk localize to lamin B-deficient microdomains and exhibit reduced gene transcription. The Journal of Pathology. 226: 735-45. PMID 22025297 DOI: 10.1002/Path.3033  0.96
2012 McGuire BB, Helfand BT, Loeb S, Hu Q, O'Brien D, Cooper P, Yang X, Catalona WJ. Outcomes in patients with Gleason score 8-10 prostate cancer: relation to preoperative PSA level. Bju International. 109: 1764-9. PMID 22017732 DOI: 10.1111/J.1464-410X.2011.10628.X  0.96
2012 Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, ... ... Helfand BT, et al. Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. The Prostate. 72: 410-26. PMID 21748754 DOI: 10.1002/Pros.21443  0.96
2011 Zhang Q, Chen L, Helfand BT, Jang TL, Sharma V, Kozlowski J, Kuzel TM, Zhu LJ, Yang XJ, Javonovic B, Guo Y, Lonning S, Harper J, Teicher BA, Brendler C, et al. TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence. Plos One. 6: e25168. PMID 21980391 DOI: 10.1371/Journal.Pone.0025168  0.96
2011 Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Nexø BA, Tjønneland A, Overvad K, ... ... Helfand BT, et al. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nature Genetics. 43: 1098-103. PMID 21946351 DOI: 10.1038/Ng.926  0.96
2011 Cooper PR, McGuire BB, Helfand BT, Loeb S, Hu Q, Catalona WJ. Prostate cancer risk alleles and their associations with other malignancies. Urology. 78: 970.e15-20. PMID 21820706 DOI: 10.1016/J.Urology.2011.05.035  0.96
2011 Helfand BT, McVary KT, Meleth S, Sharp V, Foster H, Naslund M, Williams OD. The relationship between lower urinary tract symptom severity and sleep disturbance in the CAMUS trial. The Journal of Urology. 185: 2223-8. PMID 21497839 DOI: 10.1016/J.Juro.2011.02.012  0.96
2011 O'Brien D, Loeb S, Carvalhal GF, McGuire BB, Kan D, Hofer MD, Casey JT, Helfand BT, Catalona WJ. Delay of surgery in men with low risk prostate cancer. The Journal of Urology. 185: 2143-7. PMID 21496847 DOI: 10.1016/J.Juro.2011.02.009  0.96
2011 Rebuck DA, Zhao LC, Helfand BT, Casey JT, Navai N, Perry KT, Nadler RB. Simple modifications in operating room processes to reduce the times and costs associated with robot-assisted laparoscopic radical prostatectomy. Journal of Endourology / Endourological Society. 25: 955-60. PMID 21457071 DOI: 10.1089/End.2010.0534  0.96
2011 Helfand BT, Mendez MG, Murthy SN, Shumaker DK, Grin B, Mahammad S, Aebi U, Wedig T, Wu YI, Hahn KM, Inagaki M, Herrmann H, Goldman RD. Vimentin organization modulates the formation of lamellipodia. Molecular Biology of the Cell. 22: 1274-89. PMID 21346197 DOI: 10.1091/Mbc.E10-08-0699  0.96
2011 Hartman RJ, Helfand BT, Dalton DP. Clear cell renal cell carcinoma with osseous metaplasia: a case report. The Canadian Journal of Urology. 18: 5564-7. PMID 21333055  0.96
2011 McMahon KM, Mutharasan RK, Tripathy S, Veliceasa D, Bobeica M, Shumaker DK, Luthi AJ, Helfand BT, Ardehali H, Mirkin CA, Volpert O, Thaxton CS. Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. Nano Letters. 11: 1208-14. PMID 21319839 DOI: 10.1021/Nl1041947  0.96
2011 Helfand BT, Smith ND, Kozlowski JM, Eskandari MK. Vena cava thrombectomy and primary repair after radical nephrectomy for renal cell carcinoma: single-center experience. Annals of Vascular Surgery. 25: 39-43. PMID 20889305 DOI: 10.1016/J.Avsg.2010.05.020  0.96
2011 Helfand BT, Kan D, Modi P, Catalona WJ. Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination. The Prostate. 71: 394-402. PMID 20860009 DOI: 10.1002/Pros.21253  0.96
2011 Helfand BT, Newman JP, Mongiu AK, Modi P, Meeks JJ, Gonzalez CM. Reconstruction of late-onset transplant ureteral stricture disease. Bju International. 107: 982-7. PMID 20825404 DOI: 10.1111/J.1464-410X.2010.09559.X  0.96
2010 Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, Gudjonsson SA, Stacey SN, Gylfason A, Sigurdsson A, Holm H, ... ... Helfand BT, et al. Genetic correction of PSA values using sequence variants associated with PSA levels. Science Translational Medicine. 2: 62ra92. PMID 21160077 DOI: 10.1126/scitranslmed.3001513  0.96
2010 Helfand BT, Loeb S, Kan D, Catalona WJ. Number of prostate cancer risk alleles may identify possibly 'insignificant' disease. Bju International. 106: 1602-6. PMID 20590552 DOI: 10.1111/J.1464-410X.2010.09440.X  0.96
2010 Hartman RJ, Helfand BT, McVary KT. Outcomes of lateral retroperitoneal reservoir placement of three-piece penile prosthesis in patients following radical prostatectomy. International Journal of Impotence Research. 22: 279-83. PMID 20574433 DOI: 10.1038/Ijir.2010.16  0.96
2010 Helfand BT, Manvar AM, Auffenberg GB, Blackwell R, Hartman RJ, McVary KT. Holmium laser ablation and enucleation of the prostate: a pilot study of the hybrid technique. The Canadian Journal of Urology. 17: 5190-4. PMID 20566012  0.96
2010 Helfand BT, Blackwell RH, McVary KT. Consequences of switching 5alpha-reductase inhibitors on prostate specific antigen velocity. The Journal of Urology. 184: 218-23. PMID 20483154 DOI: 10.1016/J.Juro.2010.03.020  0.96
2010 Modi P, Helfand BT, McVary KT. Medications and surgical interventions for benign prostatic hyperplasia are potential confounders of prostate-specific antigen. Current Urology Reports. 11: 224-7. PMID 20467844 DOI: 10.1007/S11934-010-0113-9  0.96
2010 Helfand BT, Fought A, Manvar AM, McVary KT. Determining the utility of recalled lower urinary tract symptoms. Urology. 76: 442-7. PMID 20346488 DOI: 10.1016/J.Urology.2009.12.052  0.96
2010 Helfand BT, Evans RM, McVary KT. A comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patients. European Urology. 57: 586-91. PMID 20036783 DOI: 10.1016/J.Eururo.2009.12.025  0.96
2010 Wang L, Wen W, Yuan J, Helfand B, Li Y, Shi C, Tian F, Zheng J, Wang F, Chen L, Liang L, Zhou L, Lee C, Chen Z, Guo Y, et al. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor β-insensitive CD8+ T cells Clinical Cancer Research. 16: 164-173. PMID 20028741 DOI: 10.1158/1078-0432.Ccr-09-1758  0.96
2010 Loeb S, Roehl KA, Helfand BT, Kan D, Catalona WJ. Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection? The Journal of Urology. 183: 112-6. PMID 19913814 DOI: 10.1016/J.Juro.2009.08.156  0.96
2010 Loeb S, Kan D, Helfand BT, Nadler RB, Catalona WJ. Is statin use associated with prostate cancer aggressiveness? Bju International. 105: 1222-5. PMID 19888973 DOI: 10.1016/S0022-5347(09)60590-5  0.96
2010 Helfand BT, McVary KT. Reply from Authors re: Roger Dmochowski. On Data Sets, Extrapolations, and Urologic Issues. Eur Urol 2010;57:592-3 European Urology. 57: 594. DOI: 10.1016/J.Eururo.2010.01.003  0.96
2009 Auffenberg GB, Helfand BT, McVary KT. Established medical therapy for benign prostatic hyperplasia. The Urologic Clinics of North America. 36: 443-59, v-vi. PMID 19942044 DOI: 10.1016/J.Ucl.2009.07.004  0.96
2009 Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, Benediktsdottir KR, Magnusdottir DN, Orlygsdottir G, Jakobsdottir M, Stacey SN, Sigurdsson A, Wahlfors T, Tammela T, Breyer JP, ... ... Helfand BT, et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nature Genetics. 41: 1122-6. PMID 19767754 DOI: 10.1038/Ng.448  0.96
2009 Kim DY, Mickelson JJ, Helfand BT, Maizels M, Kaplan WE, Yerkes EB. Fetal pyelectasis as predictor of decreased differential renal function. The Journal of Urology. 182: 1849-53. PMID 19692076 DOI: 10.1016/j.juro.2009.03.025  0.96
2009 Loeb S, Helfand BT, Kan D, Isaacs WB, Catalona WJ. Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness? Bju International. 104: 1200-3. PMID 19627283 DOI: 10.1111/J.1464-410X.2009.08656.X  0.96
2009 Polcari AJ, Kim DY, Helfand BT, Lewis JM, Chaviano AH. Pseudodistal ureteral stone resulting from calcified Deflux implantation. Urology. 74: 906-7. PMID 19616832 DOI: 10.1016/j.urology.2008.06.018  0.96
2009 Eriksson JE, Dechat T, Grin B, Helfand B, Mendez M, Pallari HM, Goldman RD. Introducing intermediate filaments: from discovery to disease. The Journal of Clinical Investigation. 119: 1763-71. PMID 19587451 DOI: 10.1172/Jci38339  0.96
2009 Pal P, Xi H, Guha S, Sun G, Helfand BT, Meeks JJ, Suarez BK, Catalona WJ, Deka R. Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry. The Prostate. 69: 1548-56. PMID 19562729 DOI: 10.1002/Pros.20999  0.96
2009 Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, et al. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3557-67. PMID 19447876 DOI: 10.1158/1078-0432.Ccr-08-1656  0.96
2009 Helfand BT, Anderson CB, Fought A, Kim DY, Vyas A, McVary KT. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia. Urology. 74: 177-83. PMID 19428074 DOI: 10.1016/J.Urology.2008.10.062  0.96
2009 Helfand BT, Mongiu AK, Roehrborn CG, Donnell RF, Bruskewitz R, Kaplan SA, Kusek JW, Coombs L, McVary KT. Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trial. The Journal of Urology. 181: 2674-9. PMID 19375101 DOI: 10.1016/J.Juro.2009.02.032  0.96
2009 Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, Catalona WJ. Pathological outcomes associated with the 17q prostate cancer risk variants. The Journal of Urology. 181: 2502-7. PMID 19371897 DOI: 10.1016/J.Juro.2009.01.109  0.96
2009 Meeks JJ, Loeb S, Helfand BT, Kan D, Smith ND, Catalona WJ. Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml. The Journal of Urology. 181: 2515-8; discussion 2. PMID 19371879 DOI: 10.1016/J.Juro.2009.01.102  0.96
2009 Helfand BT, Mongiu AK, Kan D, Kim DY, Loeb S, Roehl KA, Meeks JJ, Smith ND, Catalona WJ. Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease. Bju International. 104: 304-9. PMID 19239451 DOI: 10.1111/J.1464-410X.2009.08421.X  0.96
2009 Mongiu AK, Helfand BT, Kielb SJ. Small bowel perforation during suprapubic tube exchange. The Canadian Journal of Urology. 16: 4519-21. PMID 19222896  0.96
2009 Meeks JJ, Erickson BA, Helfand BT, Gonzalez CM. Reconstruction of urethral erosion in men with a neurogenic bladder. Bju International. 103: 378-81. PMID 18778346 DOI: 10.1111/J.1464-410X.2008.08020.X  0.96
2009 Mongiu AK, Helfand BT, Kielb SJ. Ureterovaginal fistula formation after oocyte retrieval. Urology. 73: 444.e1-3. PMID 18384861 DOI: 10.1016/J.Urology.2008.02.042  0.96
2008 Anderson CB, Helfand BT, McVary KT. Holmium laser prostatic resection for patients presenting with acute urinary retention. Bju International. 102: 1623-8. PMID 18710443 DOI: 10.1111/J.1464-410X.2008.07915.X  0.96
2008 Meeks JJ, Helfand BT, Thaxton CS, Nadler RB. Retrieval of migrated ureteral stents by coaxial cannulation with a flexible ureteroscope and paired helical basket. Journal of Endourology / Endourological Society. 22: 927-9. PMID 18429684 DOI: 10.1089/End.2007.0272  0.96
2008 Helfand BT, Loeb S, Cashy J, Meeks JJ, Thaxton CS, Han M, Catalona WJ. Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles. The Journal of Urology. 179: 2197-201; discussion. PMID 18423739 DOI: 10.1016/J.Juro.2008.01.110  0.96
2008 Loeb S, Roehl KA, Helfand BT, Catalona WJ. Complications of open radical retropubic prostatectomy in potential candidates for active monitoring. Urology. 72: 887-91. PMID 18329080 DOI: 10.1016/J.Urology.2007.12.016  0.96
2008 Meeks JJ, Thaxton CS, Loeb S, Roehl KA, Helfand BT, Catalona WJ. Comparison of prostate specific antigen velocity in screened versus referred patients with prostate cancer. The Journal of Urology. 179: 1340-3. PMID 18289590 DOI: 10.1016/J.Juro.2007.11.068  0.96
2008 Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, Kostic J, Kristinsson KT, Birgisdottir B, ... ... Helfand BT, et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nature Genetics. 40: 281-3. PMID 18264098 DOI: 10.1038/Ng.89  0.96
2006 Helfand B, Mouli S, Dedhia R, McVary KT. Management of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia With Open Prostatectomy: Results of a Contemporary Series Journal of Urology. 176: 2557-2561. PMID 17085158 DOI: 10.1016/J.Juro.2006.07.143  0.96
2006 Hillberg L, Zhao Rathje LS, NyÃ¥kern-Meazza M, Helfand B, Goldman RD, Schutt CE, Lindberg U. Tropomyosins are present in lamellipodia of motile cells. European Journal of Cell Biology. 85: 399-409. PMID 16524642 DOI: 10.1016/J.Ejcb.2005.12.005  0.96
2005 Helfand BT, Chou YH, Shumaker DK, Goldman RD. Intermediate filament proteins participate in signal transduction. Trends in Cell Biology. 15: 568-70. PMID 16213139 DOI: 10.1016/J.Tcb.2005.09.009  0.96
2004 Helfand BT, Chang L, Goldman RD. Intermediate filaments are dynamic and motile elements of cellular architecture. Journal of Cell Science. 117: 133-41. PMID 14676269 DOI: 10.1242/Jcs.00936  0.96
2003 Helfand BT, Mendez MG, Pugh J, Delsert C, Goldman RD. A role for intermediate filaments in determining and maintaining the shape of nerve cells. Molecular Biology of the Cell. 14: 5069-81. PMID 14595112 DOI: 10.1091/Mbc.E03-06-0376  0.96
2003 Helfand BT, Chang L, Goldman RD. The dynamic and motile properties of intermediate filaments. Annual Review of Cell and Developmental Biology. 19: 445-67. PMID 14570577 DOI: 10.1146/Annurev.Cellbio.19.111401.092306  0.96
2003 McGovern SL, Helfand BT, Feng B, Shoichet BK. A specific mechanism of nonspecific inhibition. Journal of Medicinal Chemistry. 46: 4265-72. PMID 13678405 DOI: 10.1021/Jm030266R  0.96
2003 Helfand BT, Loomis P, Yoon M, Goldman RD. Rapid transport of neural intermediate filament protein. Journal of Cell Science. 116: 2345-59. PMID 12711702 DOI: 10.1242/Jcs.00526  0.96
2002 Helfand BT, Mikami A, Vallee RB, Goldman RD. A requirement for cytoplasmic dynein and dynactin in intermediate filament network assembly and organization. The Journal of Cell Biology. 157: 795-806. PMID 12034772 DOI: 10.1083/Jcb.200202027  0.96
2001 Chou YH, Helfand BT, Goldman RD. New horizons in cytoskeletal dynamics: transport of intermediate filaments along microtubule tracks. Current Opinion in Cell Biology. 13: 106-9. PMID 11163141 DOI: 10.1016/S0955-0674(00)00181-2  0.96
2000 Prahlad V, Helfand BT, Langford GM, Vale RD, Goldman RD. Fast transport of neurofilament protein along microtubules in squid axoplasm. Journal of Cell Science. 113: 3939-46. PMID 11058081  0.96
1998 Silver RK, Russell TL, Brodin AG, Check IJ, Helfand BT, Caplan MS. Variability of Murine Pregnancy Outcome Resulting from Passive Immunization with Anticardiolipin Antibody-Positive Immunoglobulin G Journal of Maternal-Fetal Investigation : the Official Journal of French Society of Ultrasound in Medicine and Biology ... [Et Al.]. 8: 35-8. PMID 9524158  0.96
1997 Silver RK, Helfand BT, Russell TL, Ragin A, Sholl JS, MacGregor SN. Multifetal reduction increases the risk of preterm delivery and fetal growth restriction in twins: a case-control study. Fertility and Sterility. 67: 30-3. PMID 8986679 DOI: 10.1097/00006254-199709000-00007  0.96
Show low-probability matches.